Alan Cash Appears on Proven Health Alternatives Podcast talking about ME/CFS Research

Alan Cash Appears on Dr. Robert G. Silverman Podcast to Discuss Oxaloacetate Research in ME/CFS and Post-COVID Conditions

Alan Cash, CEO and Chief Science Officer of Terra Biological LLC, recently appeared as a guest on the podcast hosted by Robert G. Silverman to discuss emerging research on oxaloacetate and its potential applications in chronic illness, aging, and metabolic health.

Watch the Episode Now:

Focus on ME/CFS, Post-COVID, and Cellular Energy

During the episode, Cash and Silverman explored the role of oxaloacetate in supporting cellular energy metabolism, with particular attention to its relevance in conditions such as ME/CFS and post-COVID syndrome.

Cash discussed findings from ongoing research suggesting that metabolic dysfunction and impaired mitochondrial energy production may contribute to persistent fatigue symptoms. The conversation highlighted oxaloacetate’s potential role in supporting ATP production and improving cellular energy efficiency.

Longevity Science and Calorie Restriction Research

The discussion also covered broader themes in longevity science, including decades of research into calorie restriction and its relationship to aging. Cash explained how these findings informed the development of metabolic compounds designed to replicate certain physiological effects associated with calorie-restricted states.

Topics included mitochondrial function, inflammation pathways, glucose metabolism, and cognitive performance, with an emphasis on how these systems interact in both healthy aging and chronic illness.

Clinical and Research Insights

Cash referenced published and ongoing studies evaluating oxaloacetate in individuals with ME/CFS and long COVID, noting reported improvements in fatigue severity, cognitive clarity, and post-exertional malaise in some participants.

While emphasizing that research is ongoing, the discussion positioned oxaloacetate as part of a broader scientific effort to better understand metabolic contributions to chronic disease.

The work discussed on the podcast is part of the research focus behind Oxaloacetate CFS.

Continuing Scientific Dialogue

The podcast appearance reflects growing scientific interest in the intersection of metabolism, neuroinflammation, and post-viral illness. Cash and Silverman both emphasized the importance of continued clinical research to better understand potential therapeutic pathways for complex chronic conditions.

The full episode is available via Dr. Robert G. Silverman’s podcast platforms.